BridgeMD
New treatment option for Developmental Verbal Dyspraxia
Official title Speech Treatment for Minimally Verbal Children With ASD and CAS
ClinicalTrials.gov ID: NCT05066178
What this study is testing
- What it's testing
- Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 18
You may be able to join if
- Meets criteria for Autism Spectrum Disorder
- Able to correctly repeat at least 2 syllables
- Meets criteria for Childhood Apraxia of Speech
- Lives in an environment where child is exposed to English at least 50% of the time
You likely can't join if
- Poorly controlled seizures
- Factors such as blindness or deafness that contribute to minimally verbal status
- Lives in an environment where English is not spoken at least 50% of the time
- Child experiences behavioral challenges that preclude participation in the study
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.